Myofascial Release Technique in Women With Primary Dysmenorrhea

Launched by GAZI UNIVERSITY · Jul 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called myofascial release technique to see how it can help women who experience painful menstrual cramps, known as primary dysmenorrhea. The goal is to find out if this gentle hands-on therapy, which focuses on relaxing tight muscles and relieving pain, can improve menstrual symptoms and reduce muscle sensitivity in these women.

To participate in the trial, women aged 18 to 45 who have been diagnosed with primary dysmenorrhea and have regular periods with moderate to severe pain are eligible. However, women who have given birth, have other serious health issues, or are taking certain medications related to menstrual pain may not qualify. If you join the study, you will receive the myofascial release treatment and help researchers understand its effects. This trial is currently recruiting participants, so it’s a good opportunity to explore a potential new way to manage menstrual discomfort.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide,
• • Having regular menstruation in the last 6 months (28±7 days)
• • Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months
• Exclusion Criteria:
• • Diagnosed with Secondary Dysmenorrhea,
• • Having given birth,
• • Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes,
• • Undergoing urogynecological surgery,
• • Those who are pregnant or suspected of pregnancy,
• • Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain,
• • Those using intrauterine or oral contraceptives,
• • Those taking extra supplements such as magnesium, which may affect treatment